| Study | Treatment 1 | Treatment 2 | RR | 95% CI lower limit | 95% CI upper limit |
| Abril‐Molina 2021 | Levosimendan | Placebo | 0.9844 | 0.0529 | 18.3300 |
| Cavigelli‐Brunner 2018 | Dobutamine | Milrinone | 0.9245 | 0.0191 | 44.8254 |
| Costello 2014 | Milrinone | Placebo | 0.9884 | 0.0527 | 18.5311 |
| Momeni 2011 | Levosimendan | Milrinone | 0.9959 | 0.1262 | 7.8573 |
| Pellicer 2013 | Levosimendan | Milrinone | 0.9959 | 0.1262 | 7.8573 |
| Thorlacius 2020 | Levosimendan | Milrinone | 0.9959 | 0.1262 | 7.8573 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.